Find information on thousands of medical conditions and prescription drugs.

Scleroderma

Scleroderma is a rare, chronic disease characterized by excessive deposits of collagen. Progressive systemic scleroderma or systemic sclerosis, the generalised type of the disease, can be fatal. The localised type of the disease tends not to be fatal. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Sabinas brittle hair...
Saccharopinuria
Sacral agenesis
Saethre-Chotzen syndrome
Salla disease
Salmonellosis
Sandhoff disease
Sanfilippo syndrome
Sarcoidosis
Say Meyer syndrome
Scabies
Scabiophobia
Scarlet fever
Schamberg disease...
Schistosomiasis
Schizencephaly
Schizophrenia
Schmitt Gillenwater Kelly...
Sciatica
Scimitar syndrome
Sciophobia
Scleroderma
Scrapie
Scurvy
Selachophobia
Selective mutism
Seminoma
Sensorineural hearing loss
Seplophobia
Sepsis
Septo-optic dysplasia
Serum sickness
Severe acute respiratory...
Severe combined...
Sezary syndrome
Sheehan syndrome
Shigellosis
Shingles
Shock
Short bowel syndrome
Short QT syndrome
Shprintzen syndrome
Shulman-Upshaw syndrome
Shwachman syndrome
Shwachman-Diamond syndrome
Shy-Drager syndrome
Sialidosis
Sickle-cell disease
Sickle-cell disease
Sickle-cell disease
Siderosis
Silicosis
Silver-Russell dwarfism
Sipple syndrome
Sirenomelia
Sjogren's syndrome
Sly syndrome
Smallpox
Smith-Magenis Syndrome
Sociophobia
Soft tissue sarcoma
Somniphobia
Sotos syndrome
Spasmodic dysphonia
Spasmodic torticollis
Spherocytosis
Sphingolipidosis
Spinal cord injury
Spinal muscular atrophy
Spinal shock
Spinal stenosis
Spinocerebellar ataxia
Splenic-flexure syndrome
Splenomegaly
Spondylitis
Spondyloepiphyseal...
Spondylometaphyseal...
Sporotrichosis
Squamous cell carcinoma
St. Anthony's fire
Stein-Leventhal syndrome
Stevens-Johnson syndrome
Stickler syndrome
Stiff man syndrome
Still's disease
Stomach cancer
Stomatitis
Strabismus
Strep throat
Strongyloidiasis
Strumpell-lorrain disease
Sturge-Weber syndrome
Subacute sclerosing...
Sudden infant death syndrome
Sugarman syndrome
Sweet syndrome
Swimmer's ear
Swyer syndrome
Sydenham's chorea
Syncope
Syndactyly
Syndrome X
Synovial osteochondromatosis
Synovial sarcoma
Synovitis
Syphilis
Syringomas
Syringomyelia
Systemic carnitine...
Systemic lupus erythematosus
Systemic mastocytosis
Systemic sclerosis
T
U
V
W
X
Y
Z
Medicines

The term 'localised, generalised sclerderma' can be used to describe cases where the disease covers a large area of the body - typically more than 40%.

Signs and symptoms

Scleroderma affects the skin, and in more serious cases, it can affect the blood vessels and internal organs. The most evident symptom is the hardening of the skin and associated scarring. Typically the skin appears reddish or scaly in appearance. Blood vessels may also be more visible. Where large areas are affected, fat and muscle wastage will weaken limbs and affect appearance.

The seriousness of the disease varies hugely between cases. The two most important factors to consider are, the level of internal involvement (beneath the skin), and the total area covered by the disease. For example there are cases where the patient has no more than one or two lesions (affected areas), perhaps covering a few inches. These are less serious cases and tend not to involve the internal bodily functions.

Cases with larger coverage are far more likely to affect the internal tissues and organs. Where an entire limb is affected, symptoms will almost certainly have serious consequences on the use of that limb. The heart and lungs will be affected when the disease covers this area of the torso. Some patients also experience gastrointestinal problems, including heartburn and acid reflux. Internal scarring may sometimes spread beyond what can be seen by the naked eye.

There is discoloration of the hands and feet in response to cold. Most patients (>80%) have Raynaud's phenomenon, a vascular symptom that can affect the fingers, and toes.

Systemic scleroderma and Raynaud's can cause painful ulcers on the fingers or toes, which are known as digital ulcers.

Types

There are three major forms of scleroderma: diffuse, limited (CREST syndrome) and morphea/linear. Diffuse and limited scleroderma are both a systemic disease, whereas the linear/morphea form is localized to the skin. (Some physicians consider CREST and limited scleroderma one and the same, others treat them as two separate forms of scleroderma.)

Diffuse scleroderma

Diffuse scleroderma is the most severe form - it has a rapid onset, involves more widespread skin hardening, will generally cause much internal organ damage (specifically the lungs and gastrointestinal tract), and is generally more life threatening.

Limited scleroderma/CREST syndrome

The limited form is much milder: it has a slow onset and progression, skin hardening is usually confined to the hands and face, internal organ involvement is less severe, and a much better prognosis is expected.

The limited form is often referred to as "CREST" syndrome. CREST is an acronym for:

Read more at Wikipedia.org


[List your site here Free!]


Differences in right ventricular function and morphology between idiopathic and scleroderma related pulmonary arterial hypertension
From CHEST, 10/1/05 by Micah R. Fisher

PURPOSE: Idiopathic pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension related to scleroderma (PAH-SSc) are characterized by progressive increases in pulmonary vascular resistance with resultant right ventricular dysfunction, failure, and eventual death. Despite similar hemodynamics, patients with PAH-SSc have poorer response to therapy and worse outcomes. Differences in echocardiographic measures of right ventricular function and morphology may have important prognostic significance in this patient population.

METHODS: Comprehensive evaluations were performed in consecutive patients with IPAH or PAH-SSc including right heart catheterization and transthoracic echocardiograms. The echocardiograms were interpreted with special attention to right sided chamber function and morphology including right atrial and ventricular areas, eccentricity index, and tricuspid annular plane systolic excursion (TAPSE). The echocardiograms were interpreted without knowledge of the right heart catheterization results or the patient's diagnosis. The patients were then prospectively followed to determine long-term survival.

RESULTS: Thirty-three patients (15 IPAH and 18 PAH-SSc) were included in the study. Patients with PAH-SSc were older (60.5 [+ or -] 12.7 vs. 44.5 [+ or -] 12.4, P-value < 0.001). There was no difference between right atrial pressure and cardiac index between groups; however, patients with PAH-SSc had lower mean pulmonary artery pressures (45.2 [+ or -] 9.9 vs. 54.5 [+ or -] 14.5, P-value 0.036). There was a trend towards increased right atrial size and right ventricular, area, and a decreased eccentricity index for the PAH-SSc group. Pericardial effusions were more likely in the PAH-SSc patients then the patients with IPAH (50% vs. 7%, Chi-squared=0.007). Right ventricular function as measured by TAPSE was significantly reduced in the PAH-SSc group (1.7 [+ or -] 0.5 vs 2.1 [+ or -] 0.7, P-value 0.042). One-year outcomes are pending.

CONCLUSION: Patients with PAH-SSc have reduced right ventricular function and are more likely to have a pericardial effusion present despite having milder pulmonary hypertension. These results suggest that the right ventricle in patients with PAH-SSc is less adaptable to elevation in pulmonary artery pressure.

CLINICAL IMPLICATIONS: Echocardiographic measurements of right ventricular function may have prognostic significance for long-term survival.

DISCLOSURE: Micah Fisher, None.

Micah R. Fisher MD * Paul R. Forfia MD Ela Chamera Reda E. Girgis MB, BCh Mary Corretti MD Paul M. Hassoun MD Johns Hopkins University, Baltimore, MD

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Scleroderma
Home Contact Resources Exchange Links ebay